Stage IVB Rectal Cancer Withdrawn Phase Trials for Aflibercept (DB08885)

IndicationStatusPhase
DBCOND0028589 (Stage IVB Rectal Cancer)WithdrawnNot Available
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01941173Short-Infusion Ziv-aflibercept in Treating Patients With Metastatic Colorectal Cancer Receiving Combination ChemotherapyTreatment